2cureX will participate at Sedermeradagen Copenhagen

February 27 | 2018
2cureX AB (“2cureX”) will participate at Sedermeradagen Copenhagen on the 13th of March 2018. Sedermeradagen is an investment conference, arranged by Sedermera Fondkommission with the purpose of providing a day of interesting company presentations and company interviews within the micro- and small cap segment. Participation is free of charge and the event will be held at Copenhagen Marriott Hotel.

Sedermeradagen Copenhagen will be held at Copenhagen Marriott Hotel on Tuesday, March 13th, 2018. Sedermeradagen begins with breakfast at 07:30. Company presentations will start at 08:00. Ole Thastrup, CEO of 2cureX, will be representing as speaker. Sedermeradagen will contain a coffee break and ends with a lunch where it will be possible to talk with 2cureX’s representatives.

Sedermeradagen Copenhagen is arranged by Sedermera Fondkommission and participation is free. For further information and registration, please visit http://www.sedermera.se/evenemang/2018-03-13/sedermeradagen-kopenhamn-133. Please note that the seating is limited.

Certified Adviser

Sedermera Fondkommission is the Certified Adviser of 2cureX. 

For more information about 2cureX:

Ole Thastrup, CEO

E-mail: ot@2cureX.com

Phone: +45 22 11 53 99

URL: www.2curex.com

About 2cureX

2cureX has developed IndiTreat ™ (Individual Treatment Design) – a patented method for selecting the right drug for the right patient, thereby improving cancer treatment. Initially, IndiTreat™ is targeted towards colorectal cancer; but the method is applicable to additional cancer indications (e.g. ovarian, breast and kidney cancer). The company is listed at the Nasdaq First North stock exchange in Stockholm (symbol “2CUREX”).